Recombinant Drosophila melanogaster G-protein coupled receptor moody (moody)

What are the key structural characteristics of Moody GPCR in Drosophila melanogaster?

Moody is a Rhodopsin-family GPCR encoded by the moody gene that produces two isoforms through alternative splicing: Moody-α and Moody-β. Both proteins share identical membrane-spanning domains but differ significantly in their carboxy-terminal cytoplasmic domains, which are generated by use of alternative reading frames. The receptor contains the characteristic seven-transmembrane structure of GPCRs with specific residues such as asparagine, tryptophan, and proline that stabilize the transmembrane domains. Moody is expressed on the basal, brain-facing surface of the subperineurial glia (SPG) in the blood-brain barrier .

How do the two Moody isoforms (Moody-α and Moody-β) differ functionally?

While either Moody-α or Moody-β isoform is sufficient for basic blood-brain barrier formation and structural integrity, both isoforms are required simultaneously for more complex functions including proper behavioral responses (such as normal courtship behavior and drug sensitivity). RNA sequencing data suggests the two isoforms are not present in equal abundance, and their ratio appears to be sex-specifically regulated. The difference in their intracellular domains suggests they interact with different downstream effector molecules, both contributing to behavioral responses, though through potentially distinct signaling mechanisms . Neither isoform can fully compensate for the absence of the other in behavioral contexts, indicating complementary but non-redundant functions .

What is known about the ligand(s) for Moody GPCR?

Moody is currently classified as an orphan GPCR, meaning its endogenous ligand(s) remain unidentified. This represents a significant gap in our understanding of Moody signaling. Given Moody's expression on the neuronal-facing surface of the subperineurial glia, it's hypothesized that the ligand may be a neuron-derived signaling molecule that communicates neuronal states (e.g., related to sleep) to the BBB glia. Identifying Moody's ligand(s) remains an important research priority that would help elucidate how the receptor is activated in different physiological contexts .

What are the established genetic approaches for studying Moody function in Drosophila?

Several genetic approaches have been validated for studying Moody function:

Loss-of-function approaches:

• moodyΔ17 null mutants (typically lethal with few adult escapers)

• Conditional knockdown using RNAi with moody-Gal4 or SPG-Gal4 drivers

• Temperature-sensitive Gal80ts system for temporal control of knockdown in adults

• Tissue-specific knockdown using repo-GeneSwitch for induction with RU486

Rescue experiments:

• moodyΔ17; moody-α or moodyΔ17; moody-β flies to study isoform-specific functions

• Combination of both transgenes to restore normal function

Functional manipulation:

• Sex-specific feminization of the BBB using TraF expression

• Pertussis toxin (PTX) expression to inhibit Go signaling

• Expression of constitutively active or dominant-negative G-protein subunits

What assays are used to measure BBB integrity in Moody studies?

Several complementary approaches are used to assess BBB integrity:

Dye penetration assay:

• Injection of fluorescent dyes (typically 10 kDa dextran dyes) into the hemolymph

• Quantification of dye penetration into the central nervous system

• Time-course imaging to measure barrier dynamics

Electrical resistance measurements:

• Recording transepithelial resistance across the BBB

Molecular marker analysis:

• Immunostaining for septate junction components

• Assessment of septate junction continuity and organization

Ultrastructural analysis:

• Electron microscopy to examine septate junction ultrastructure

• 3D reconstruction to measure continuity of individual septate junction segments

For adult studies, dye injection is typically performed in the abdomen, while in larvae, dye can be introduced through body wall puncture. Quantification involves measuring fluorescence intensity in the CNS relative to the surrounding tissue .

How can one effectively express and characterize recombinant Moody protein for in vitro studies?

For recombinant expression and characterization of Moody:

Expression systems:

• Drosophila S2 cells provide a native-like environment with appropriate post-translational modifications

• High Five insect cells yield higher protein levels

• HEK293 cells can be used with codon optimization

Protein purification approach:

• Add epitope tags (His6, FLAG, or HA) to either N-terminus (after signal sequence) or C-terminus

• Use detergent screening (typically DDM, LMNG, or GDN) for membrane extraction

• Employ affinity chromatography followed by size exclusion chromatography

• Verify protein quality by SDS-PAGE and Western blotting with isoform-specific antibodies

Functional characterization:

• GTPγS binding assays to measure G-protein activation

• BRET/FRET assays to study protein-protein interactions

• Calcium mobilization assays if coupled to Gq proteins

• Surface plasmon resonance for potential ligand screening

The choice of tag position is critical as C-terminal tagging may interfere differently with the two isoforms due to their distinct C-terminal domains .

How does Moody signaling regulate blood-brain barrier formation and maintenance?

Moody regulates BBB through multiple coordinated mechanisms:

Development and formation:

• PKA activation by Moody signaling controls the developmental assembly of septate junction belts

• Coordinates spatiotemporal rearrangements of the actin cytoskeleton

• Regulates vesicular trafficking of septate junction components

• Influences cell shape and polarized cell function

Maintenance in adults:

• Continuous signaling required for BBB integrity

• Formation of actin-rich structures (ARSs) along lateral SPG borders

• Regulation of myosin activation and actomyosin contractility

• Control of specialized glia growth during larval and adult stages

Molecular targets:

• MLCK (Myosin Light Chain Kinase) and Rho1 are direct targets of PKA downstream of Moody

• Proper organization of septate junctions depends on continuity of individual segments rather than total length

The dual-isoform requirement suggests that Moody-α and Moody-β may regulate different aspects of this process, potentially through differential engagement of downstream effectors .

What is the role of Moody in regulating courtship behavior and how does it differ between sexes?

Moody functions in a sex-specific manner to regulate courtship:

Male-specific functions:

• Male identity of the BBB is necessary for normal male courtship behavior

• Feminization of the BBB in otherwise normal males significantly reduces courtship index

• Both Moody-α and Moody-β isoforms are required for normal courtship

• The ratio of Moody isoforms appears to be regulated by the sex-specific splicing factor TraF

Signaling mechanisms:

• Go signaling downstream of Moody is required for courtship

• Potential interaction with dopamine receptor D2R, which is also expressed in BBB and required for male courtship

• Sex-specific molecules in the BBB likely interact with Moody signaling

Experimental evidence:

• Adult-specific feminization of the BBB reduces male courtship, indicating an active physiological role rather than developmental

• Conditional manipulation of Go signaling in adults affects courtship

• The BBB integrity remains intact during these manipulations, suggesting specific signaling roles

This suggests that the BBB serves as an interface between circulating factors and the sex-specific neural circuits controlling courtship, with Moody as a key mediator of this interaction .

How does Moody signaling interact with sleep regulation in Drosophila?

Moody plays a central role in sleep regulation through BBB modulation:

Sleep-wake cycle effects:

• Sleep deprivation rapidly depresses moody expression

• moody levels are 60-90% lower in sleep mutant flies

• Adult-specific knockdown of moody in the BBB causes sleep loss

• Sleep fragmentation occurs with increased BBB permeability

Bidirectional relationship:

• BBB permeability increases in a dose-dependent manner with sleep deprivation

• BBB closes rapidly when sleep is recovered

• Permeability changes are dynamic and reversible

• Sleep recovery restores moody expression levels

Downstream effects:

• Altered BBB permeability may allow passage of sleep-regulating molecules

• Changes in BBB permeability potentially affect ionic homeostasis

• Moody signaling through PKA may regulate endocytosis at the BBB during sleep/wake cycles

This suggests a model where neuronal activation during wakefulness affects Moody signaling to increase BBB permeability, which may itself be part of the sleep regulatory mechanism .

How can conflicting results between different Moody signaling mutants be reconciled?

Researchers often encounter seemingly contradictory results when studying Moody signaling components. Several methodological approaches can help reconcile these conflicts:

Address genetic background effects:

• Compare mutants after backcrossing to identical genetic backgrounds (minimum 5-10 generations)

• Use precise genetic controls with the same insertions but lacking the mutation/RNAi construct

• Employ CRISPR/Cas9 to generate mutations on identical backgrounds

Consider dosage-dependent effects:

• Different protein levels from hypomorphic alleles versus complete knockouts

• Partial compensation by related genes at different expression levels

• Quantify protein levels by Western blot to correlate with phenotypic severity

Examine timing-dependent effects:

• Use temperature-sensitive systems to manipulate gene expression at different developmental stages

• Compare acute versus chronic manipulations

• Consider potential developmental compensation versus acute requirements

Example resolution approach:
For conflicting results in moody loco double mutants (where genomic double mutants show worse insulation defects than loco alone, while RNAi double mutants resemble moody alone), carefully quantify remaining protein levels and determine whether threshold effects exist where certain phenotypes manifest only below specific protein concentrations .

What approaches can identify the unknown ligand for Moody GPCR?

Identifying Moody's ligand(s) requires a multi-faceted strategy:

Candidate molecule screening:

• Test neuropeptides and small molecules expressed in neurons adjacent to the BBB

• Screen fractionated Drosophila brain extracts using functional assays

• Examine molecules upregulated during processes requiring active Moody signaling (sleep deprivation, courtship)

Cell-based screening system:

• Express Moody in heterologous cells with biosensors (calcium indicators, cAMP reporters)

• Design assays for Go/Gi coupling (measuring cAMP inhibition)

• Develop BRET/FRET-based assays to monitor conformational changes upon ligand binding

• Screen compound libraries and tissue extracts

Bioinformatic approaches:

• Sequence comparison with related GPCRs that have known ligands

• Machine learning predictions based on binding pocket characteristics

• Molecular docking simulations with candidate ligands

Unbiased genetic screens:

• Screen for mutations affecting Moody-dependent phenotypes

• Identify genetic suppressors of moody mutant phenotypes

• Use proximity labeling (BioID/TurboID) to identify proteins interacting with Moody in vivo

Combining these approaches with advanced structural biology methods (cryo-EM) could illuminate the molecular recognition properties of Moody .

What are the molecular mechanisms explaining how Moody differentially regulates diverse physiological processes?

The diverse functions of Moody likely involve distinct molecular mechanisms:

Isoform-specific signaling:

• Design experiments comparing signaling outputs between Moody-α and Moody-β

• Use phosphoproteomics to identify differential phosphorylation targets

• Generate chimeric receptors to map domains responsible for specific functions

Spatiotemporal regulation:

• Develop optogenetic tools to activate Moody signaling in specific subpopulations of glia

• Employ tissue-specific rescue experiments with subcellular targeting sequences

• Utilize live imaging with labeled Moody variants to track receptor dynamics

G-protein coupling specificity:

• Measure G-protein selectivity using BRET/FRET biosensors

• Identify residues governing G-protein specificity through mutagenesis

• Analyze the dynamics of receptor-G protein interactions in different contexts

Downstream pathway analysis:

• Compare transcriptional responses to Moody activation in different contexts

• Create biosensors for downstream effectors (PKA, Rho1) to measure local activation

• Employ suppressor/enhancer genetic screens to identify context-specific pathways

A comprehensive approach would combine these methods to create pathway maps for each Moody function, potentially revealing how the same receptor can coordinate distinct physiological processes through differential engagement of signaling components .

How can contradictory effects of Moody on both BBB integrity and behavioral regulation be experimentally dissociated?

To dissociate BBB integrity functions from behavioral regulation:

Structure-function analysis:

• Generate point mutations that selectively affect G-protein coupling versus BBB integrity

• Create phosphorylation site mutants to disrupt specific downstream pathways

• Design domain swaps between Moody and related GPCRs that don't affect behavior

Temporal manipulation approach:

• Use adult-specific manipulations that don't compromise BBB integrity (verified by dye injection)

• Employ rapid chemogenetic or optogenetic tools to activate/inhibit signaling without affecting barrier structure

• Measure both BBB integrity and behavior in the same animals to establish correlations

Pathway-specific interventions:

• Target specific downstream components (e.g., PKA inhibition) that might selectively affect behavior versus BBB structure

• Manipulate cytoskeletal regulators downstream of Moody that specifically affect junctions versus signaling

• Identify behavioral modifiers that don't affect BBB integrity

Example experimental design:
Use a CRISPR-generated mutant that maintains BBB integrity but disrupts G-protein coupling (moody^G-mut^) and compare to wild-type and null alleles across behavioral assays. The data could be presented in a table showing BBB integrity measurements and behavioral outcomes across genotypes:

This would demonstrate that BBB integrity can be uncoupled from behavioral functions, suggesting separable signaling mechanisms .

What methodological approaches can determine if Moody signaling has a conserved role in mammalian BBB function?

To explore evolutionary conservation of Moody functions:

Comparative genomics approach:

• Identify closest mammalian homologs using sequence analysis and phylogenetics

• Compare expression patterns in mammalian BBB cells versus other tissues

• Analyze conservation of key functional domains and signaling motifs

Cross-species functional complementation:

• Express mammalian homologs in moody mutant flies to test rescue of phenotypes

• Create knock-in flies with mammalian receptor domains substituted for Moody domains

• Test if Drosophila Moody can function in mammalian BBB cell culture models

Translational research approaches:

• Examine mammalian homolog expression changes during sleep deprivation

• Test if drugs affecting Moody in flies have similar effects on mammalian BBB

• Study mammalian homolog knockout models for BBB phenotypes similar to fly moody mutants

Signaling conservation analysis:

• Compare downstream signaling pathways between flies and mammals

• Test if manipulating homologous pathways affects mammalian BBB similarly

• Employ proteomics to identify conserved interaction partners

This cross-species approach could reveal fundamental mechanisms of BBB regulation conserved from insects to mammals, potentially identifying new therapeutic targets for BBB manipulation in neurological disorders .